COMMUNIQUÉS West-GlobeNewswire

Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma
17/06/2025
HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of [...]
Ashvattha Therapeutics to Present Data on Novel Nanomedicine Radiotracers at SNMMI Annual Meeting
17/06/2025
Company to showcase breakthrough imaging agents advancing precision medicine in neurology and oncology REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage [...]
Scienture Holdings Announces Cancelation of ELOC
17/06/2025
TAMPA, FL, June 17, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to [...]
IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™
17/06/2025
Clinical Data Highlight PlaCCine’s Six-Month Durability, Temperature Stability, and Manufacturing Advantages Over mRNA Vaccines IMUNON Seeks Strategic Partner for PlaCCine ® to Advance Novel Technology and Fund Core [...]
CHO Plus Selected for 2025 BioTools Innovator Accelerator Program
17/06/2025
Biomanufacturing Technology Developer Joins Top-Tier Global Cohort Competing for $300,000 in Cash Awards SOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Privately-held CHO Plus, Inc., a leading developer [...]
FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES NEW WOUND CARE SERVICES OFFERING
17/06/2025
WEST PALM BEACH, FLORIDA, June 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “ Company ”) today announced that its critical access hospital, Big South Fork Medical Center [...]
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
17/06/2025
Significant Development Supports Long-Term Global Commercial Strategy of the LIBERTY® System HINGHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY [...]
X-Chem Strengthens Executive Team with Strategic Finance and HR Appointments
17/06/2025
New leaders join X-Chem to support operational excellence and partner success across data-driven discovery programs WALTHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in data-driven drug discovery [...]
Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
17/06/2025
PITTSBURGH, June 17, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with [...]
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis
17/06/2025
VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the United States Patent and [...]
AIM ImmunoTech Resumes Trading on NYSE American
17/06/2025
Company trading under the ticker “AIM” NYSE American effective at the start of trading today, Tuesday, June 17th OCALA, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “ [...]
Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner
17/06/2025
Award celebrates bold leaders shaping the future through the world’s most ground-breaking companies POMPANO BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) announced that Jason Matuszewski, [...]
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
17/06/2025
--New CCO to Lead U.S. Commercialization of Fertility Products, Including FemaSeed ® , and Expand Strategic Global Partnerships Across Full Portfolio-- ATLANTA, June 17, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc. (Nasdaq: [...]
Lark Health Names Industry Veteran Matthew Gibbs as President and Launches LarkVantage, an A.I. GLP-1 Cost Containment Platform
17/06/2025
Former PBM and health plan executive to spearhead innovative launch of a breakthrough A.I.-powered platform for streamlining GLP-1 authorization MOUNTAIN VIEW, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Lark Health , a [...]
LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets
17/06/2025
LOUISVILLE, Ky, June 17, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing safety and care [...]
BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
17/06/2025
Company to generate and analyze molecular profiles from over 17,000 samples from the HUNT Biobank in Norway to accelerate discovery of drug targets for aging-related diseases New data deepen platform insights into the [...]
Alira Health Launches Patient Engagement Certification for Life Sciences Organizations
17/06/2025
FRAMINGHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Alira Health is a global healthcare consultancy that helps life sciences companies deliver patient-centered solutions through integrated clinical, strategic, and [...]
Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program
17/06/2025
U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s focus in neuromuscular diseases Capricor remains on track for the August 31, 2025, PDUFA date [...]
Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
17/06/2025
$452.5 million in total milestone payments $2.5 million in near-term payments Double-digit royalties on future net product sales 3.5% equity stake in Intact Therapeutics HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- [...]

Pages